Arrowstreet Capital’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.02B | Sell |
2,165,258
-145,854
| -6% | -$73.4M | 0.55% | 30 |
|
|
2025
Q4 | $1.08B | Buy |
2,311,112
+245,887
| +12% | +$114M | 0.63% | 24 |
|
|
2025
Q3 | $880M | Buy |
2,065,225
+36,414
| +2% | +$14.1M | 0.56% | 30 |
|
|
2025
Q2 | $777M | Sell |
2,028,811
-74,735
| -4% | -$26.9M | 0.55% | 32 |
|
|
2025
Q1 | $727M | Sell |
2,103,546
-416,291
| -17% | -$134M | 0.59% | 27 |
|
|
2024
Q4 | $756M | Sell |
2,519,837
-32,127
| -1% | -$11.2M | 0.61% | 25 |
|
|
2024
Q3 | $1.04B | Buy |
2,551,964
+30,837
| +1% | +$11.3M | 0.88% | 14 |
|
|
2024
Q2 | $810M | Sell |
2,521,127
-55,970
| -2% | -$18.2M | 0.71% | 25 |
|
|
2024
Q1 | $860M | Sell |
2,577,097
-121,923
| -5% | -$37.3M | 0.79% | 23 |
|
|
2023
Q4 | $731M | Sell |
2,699,020
-550,439
| -17% | -$136M | 0.77% | 23 |
|
|
2023
Q3 | $799M | Buy |
3,249,459
+255,488
| +9% | +$69.9M | 0.97% | 18 |
|
|
2023
Q2 | $909M | Buy |
2,993,971
+1,531,395
| +105% | +$426M | 1.1% | 13 |
|
|
2023
Q1 | $386M | Sell |
1,462,576
-139,717
| -9% | -$35.5M | 0.5% | 49 |
|
|
2022
Q4 | $384M | Sell |
1,602,293
-420,870
| -21% | -$94.3M | 0.54% | 48 |
|
|
2022
Q3 | $372M | Sell |
2,023,163
-799,239
| -28% | -$159M | 0.55% | 43 |
|
|
2022
Q2 | $474M | Buy |
2,822,402
+21,555
| +0.8% | +$4.63M | 0.67% | 32 |
|
|
2022
Q1 | $702M | Buy |
2,800,847
+347,177
| +14% | +$87.2M | 0.88% | 22 |
|
|
2021
Q4 | $630M | Buy |
2,453,670
+161,433
| +7% | +$39.5M | 0.77% | 17 |
|
|
2021
Q3 | $556M | Buy |
2,292,237
+39,947
| +2% | +$9.77M | 0.7% | 19 |
|
|
2021
Q2 | $466M | Buy |
2,252,290
+468,669
| +26% | +$95.5M | 0.57% | 26 |
|
|
2021
Q1 | $336M | Buy |
1,783,621
+143,058
| +9% | +$25.2M | 0.45% | 42 |
|
|
2020
Q4 | $270M | Sell |
1,640,563
-87,756
| -5% | -$12.8M | 0.38% | 49 |
|
|
2020
Q3 | $215M | Buy |
1,728,319
+379,387
| +28% | +$47M | 0.34% | 41 |
|
|
2020
Q2 | $131M | Buy |
1,348,932
+199,680
| +17% | +$20.8M | 0.24% | 78 |
|
|
2020
Q1 | $103M | Sell |
1,149,252
-166,945
| -13% | -$21.6M | 0.29% | 63 |
|
|
2019
Q4 | $195M | Sell |
1,316,197
-736,687
| -36% | -$98.9M | 0.45% | 42 |
|
|
2019
Q3 | $247M | Sell |
2,052,884
-1,398,377
| -41% | -$181M | 0.58% | 37 |
|
|
2019
Q2 | $467M | Sell |
3,451,261
-588,108
| -15% | -$74.4M | 1.04% | 14 |
|
|
2019
Q1 | $527M | Sell |
4,039,369
-31,100
| -0.8% | -$4.18M | 1.25% | 12 |
|
|
2018
Q4 | $507M | Sell |
4,070,469
-286,721
| -7% | -$38.5M | 1.33% | 10 |
|
|
2018
Q3 | $606M | Buy |
4,357,190
+835,093
| +24% | +$104M | 1.37% | 13 |
|
|
2018
Q2 | $361M | Buy |
3,522,097
+755,384
| +27% | +$76.4M | 0.88% | 22 |
|
|
2018
Q1 | $268M | Sell |
2,766,713
-214,242
| -7% | -$20.8M | 0.62% | 38 |
|
|
2017
Q4 | $262M | Sell |
2,980,955
-339,485
| -10% | -$27.3M | 0.63% | 36 |
|
|
2017
Q3 | $264M | Buy |
3,320,440
+432,756
| +15% | +$34.8M | 0.71% | 40 |
|
|
2017
Q2 | $252M | Buy |
2,887,684
+580,084
| +25% | +$49.1M | 0.76% | 29 |
|
|
2017
Q1 | $205M | Buy |
+2,307,600
| New | +$192M | 0.75% | 27 |
|
|
2016
Q4 | – | Sell |
-1,369,679
| Closed | -$104M | – | 2012 |
|
|
2016
Q3 | $104M | Buy |
1,369,679
+271,778
| +25% | +$20.8M | 0.34% | 63 |
|
|
2016
Q2 | $84.5M | Sell |
1,097,901
-332,480
| -23% | -$26.2M | 0.28% | 97 |
|
|
2016
Q1 | $112M | Sell |
1,430,381
-225,190
| -14% | -$15.7M | 0.47% | 40 |
|
|
2015
Q4 | $112M | Sell |
1,655,571
-1,097,194
| -40% | -$76.5M | 0.52% | 38 |
|
|
2015
Q3 | $213M | Buy |
2,752,765
+167,400
| +6% | +$14.8M | 1.01% | 16 |
|
|
2015
Q2 | $235M | Buy |
2,585,365
+462,165
| +22% | +$37M | 1.33% | 8 |
|
|
2015
Q1 | $160M | Sell |
2,123,200
-1,686,590
| -44% | -$121M | 0.98% | 18 |
|
|
2014
Q4 | $280M | Buy |
3,809,790
+728,598
| +24% | +$51.2M | 1.6% | 6 |
|
|
2014
Q3 | $217M | Buy |
3,081,192
+1,122,612
| +57% | +$74.2M | 1.17% | 15 |
|
|
2014
Q2 | $110M | Buy |
1,958,580
+557,000
| +40% | +$29.4M | 0.57% | 40 |
|
|
2014
Q1 | $73.6M | Sell |
1,401,580
-451,423
| -24% | -$22.5M | 0.45% | 55 |
|
|
2013
Q4 | $88.4M | Sell |
1,853,003
-744,361
| -29% | -$34.4M | 0.48% | 56 |
|
|
2013
Q3 | $111M | Sell |
2,597,364
-2,246,051
| -46% | -$87.8M | 0.71% | 31 |
|
|
2013
Q2 | $175M | Buy |
+4,843,415
| New | +$187M | 1.3% | 12 |
|
Other funds holding HCA
VCM
VPM
Arrowstreet Capital's HCA Position: Q1 2026 in Review
Arrowstreet Capital reduced its HCA Healthcare (HCA) stake by 6.3% in Q1 2026, selling an estimated $73.4M and leaving 2,165,258 shares worth $1.02B. The position accounts for 0.55% of the portfolio, ranked #30.
Arrowstreet Capital first reported a position in HCA in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.08B in Q4 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Arrowstreet Capital held 2,165,258 shares of HCA Healthcare worth $1.02B as of Q1 2026.
- Arrowstreet Capital sold 145,854 HCA Healthcare shares in Q1 2026, an estimated $73.4M.
- HCA Healthcare made up 0.55% of Arrowstreet Capital's portfolio in Q1 2026, its #30 holding.
- Arrowstreet Capital first reported a position in HCA Healthcare in Q2 2013 and has held it in 51 quarters since.
- Arrowstreet Capital's HCA Healthcare position peaked at $1.08B in Q4 2025.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.